My thoughts are at the moment are that at the next board meeting they will consider the expert advice on the trial and make a decision about whether to extend monitoring for 6 more months to clarify the result, go ahead with a submission to Medsafe with the data they have, or give up on the trial.
Currently my bet is the first option.
Recent events, page-98
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $21.26K | 3.022M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 8514049 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1168300 | 11 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |